CMND
Income statement / Annual
Last year (2023), Clearmind Medicine Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Clearmind Medicine Inc.'s net income was -$11.96 M.
See Clearmind Medicine Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
10/31/2023 |
10/31/2022 |
10/31/2021 |
10/31/2020 |
10/31/2019 |
10/31/2018 |
10/31/2017 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$56,342.00 |
$113,379.00 |
$2,572.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$56,342.00 |
-$113,379.00 |
-$2,572.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$2.14 M
|
$2.98 M
|
$646,487.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$6.60 M
|
$5.43 M
|
$3.03 M
|
$233,220.00
|
$105,283.00
|
$254,535.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$6.60 M
|
$5.43 M
|
$3.03 M
|
$233,220.00
|
$105,283.00
|
$254,535.00
|
$6,671.00
|
| Other Expenses |
$0.00 |
$113,378.00 |
$0.00 |
$0.00 |
$0.00 |
$60,000.00 |
$0.00 |
| Operating Expenses |
$8.74 M |
$8.53 M |
$3.68 M |
$233,220.00 |
$105,283.00 |
$254,535.00 |
$6,671.00 |
| Cost And Expenses |
$8.74 M |
$8.53 M |
$3.68 M |
$233,220.00 |
$105,283.00 |
$254,535.00 |
$6,671.00 |
| Interest Income |
$57,972.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$19,678.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$30,687.00
|
$113,379.00
|
$2,572.00
|
$179,689.00
|
$86,005.00
|
$161,141.00
|
$0.00
|
| EBITDA |
-$8.71 M
|
-$8.49 M
|
-$3.67 M
|
-$233,220.00
|
$0.00
|
-$56,272.00
|
-$6,670.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$3.19 M
|
-$835,858.90
|
-$43,528.00
|
-$179,689.00
|
$0.00
|
$60,000.00
|
-$1.00
|
| Income Before Tax |
-$11.93 M |
-$9.37 M |
-$3.90 M |
-$233,220.00 |
-$105,283.00 |
-$194,535.00 |
-$6,671.00 |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$24,090.00 |
$40,754.00 |
$223,218.00 |
-$385,986.00 |
-$171,863.00 |
-$60,000.00 |
$0.00 |
| Net Income |
-$11.96 M |
-$9.41 M |
-$4.12 M |
-$233,220.00 |
-$105,283.00 |
-$194,535.00 |
-$6,671.00 |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-59.18 |
-217.17 |
-133.37 |
-12.86 |
-8.54 |
-18.05 |
-0.55 |
| EPS Diluted |
-59.04 |
-217.17 |
-133.37 |
-12.86 |
-8.54 |
-18.05 |
-0.55 |
| Weighted Average Shares
Out |
$202,000.00
|
$43,334.00
|
$30,911.00
|
$18,130.00
|
$12,333.00
|
$10,779.00
|
$12,222.00
|
| Weighted Average Shares
Out Diluted |
$202,481.00
|
$43,334.00
|
$30,911.00
|
$18,130.00
|
$12,333.00
|
$10,779.00
|
$12,222.00
|
| Link |
|
|
|
|
|
|
|
